← Back
Data updated: Mar 10, 2026
ANBISON LAB
Neurology
ANBISON LAB is a generic drug manufacturer focused on Neurology.
2015
Since
3
Drugs
-
Trials
138
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
BUPROPION HYDROCHLORIDE 2026-02-25
Labeling
CARBAMAZEPINE 2026-01-05
Labeling
BUPROPION HYDROCHLORIDE 2025-11-06
Labeling
BUPROPION HYDROCHLORIDE 2025-11-06
Labeling
BUPROPION HYDROCHLORIDE 2025-11-06
Labeling
BUPROPION HYDROCHLORIDE 2025-11-06
Labeling
BUPROPION HYDROCHLORIDE 2025-11-06
Labeling
BUPROPION HYDROCHLORIDE 2025-11-06
Labeling
BUPROPION HYDROCHLORIDE 2025-11-06
Labeling
BUPROPION HYDROCHLORIDE 2025-11-06
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (2)
Company Info
- First Approval
- 2015-11-05
- Latest
- 2024-10-07
- Applications
- 4